SG Americas Securities, LLC - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 133 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q3 2023$1,938
+700.8%
75,845
+652.0%
0.02%
+633.3%
Q1 2023$242
-99.9%
10,086
-55.5%
0.00%
-25.0%
Q2 2022$357,000
+61.5%
22,678
+280.2%
0.00%
+300.0%
Q4 2021$221,000
-68.7%
5,965
-59.6%
0.00%
-66.7%
Q3 2021$706,000
+132.2%
14,767
+100.8%
0.00%
+50.0%
Q1 2021$304,000
-60.5%
7,355
-59.0%
0.00%
-60.0%
Q3 2020$769,000
+122.9%
17,931
+143.0%
0.01%
+66.7%
Q2 2020$345,0007,3800.00%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q1 2022
NameSharesValueWeighting ↓
Tri Locum Partners LP 208,886$5,337,0371.71%
Portolan Capital Management 276,505$7,064,7030.66%
Nikko Asset Management Americas, Inc. 1,388,574$35,422,5230.42%
Green Alpha Advisors, LLC 21,538$550,2960.42%
SummerHaven Investment Management, LLC 22,326$570,4290.42%
ARK Investment Management 1,901,546$48,584,5080.37%
Granahan Investment Management 398,862$10,190,9240.36%
FEDERATED HERMES, INC. 4,711,512$120,379,1320.32%
Woodline Partners LP 1,069,814$27,333,7480.32%
Diametric Capital, LP 26,130$667,6210.28%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders